HALO - Halozyme Therapeutics Inc. (HALO) CEO Helen Torley on Q3 2019 Results - Earnings Call Transcript
Halozyme Therapeutics, Inc. (HALO)
Q3 2019 Earnings Conference Call
November 12, 2019 4:30 PM ET
Company Participants
Albert Kildani - Vice President of Investor Relations and Corporate Communications
Helen Torley - President and Chief Executive Officer
Laurie Stelzer - Chief Financial Officer
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Jim Birchenough - Wells Fargo
Jason Butler - JMP Securities
Jessica Fye - JP Morgan
Joel Beatty - Citi
Presentation
Operator
Good afternoon everyone. I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for